大蒜素药理作用研究的最新进展  

Recent Advances in Study of Pharmacological Action of Garlicin

作　　者：胡玉熙[1] 陈曦[1] 刘清飞[1] 徐牧 王义明[1] 罗国安[1] 

机构地区：[1]清华大学生命科学与医学研究院 [2]珠海生物医药新型制剂研发中心,广东珠海519085

出　　处：《药学进展》2007年第11期481-485,共5页Progress in Pharmaceutical Sciences

基　　金：清华大学-裕元医学研究基金(20240000548;20240000529)

摘　　要：综述近年来大蒜素对病原微生物、心脑血管系统、肿瘤、肝脏以及糖代谢等的药理作用研究进展。大蒜素为大蒜中主要的天然生物活性成分,具广泛的药理活性,其不良反应小,临床应用前景广阔,值得进一步研究与开发。The advances in study of pharmacological action of garlicin on pathogenic microorganism, cardiocerebral vascular system, tumor, liver and glucose metabolism in recent years were reviewed. Garlicin, a main garlic active principle, has shown a wide pharmacological activity with less adverse reactions. So it is well-prospective in clinic and worth further reseaching and developing.

关 键 词：大蒜素 药理作用 病原微生物 心脑血管系统 肿瘤 肝脏 糖代谢 

分 类 号：R285.5[医药卫生—中药学]